SARS‐CoV‐2 S1 and N‐based serological assays reveal rapid seroconversion and induction of specifc antibody response in COVID‐19 patients
As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2, continues to spread rapidly around the world, there is a need for well validated serological assays that allow the detection of viral specifc antibody responses in COVID-19 patients or recovered individuals. In this...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14392
- Acceso en línea:
- https://doi.org/10.1038/s41598-020-73491-5
http://hdl.handle.net/20.500.12010/14392
- Palabra clave:
- SARS‑CoV‑2 S1
N‑based serological
COVID‑19
Specifc antibody response
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)